Novartis

ILARIS

Manufacturer:

Novartis

Ilaris HCPCS:

J0638

HCPCS Code Descriptor:

Injection, canakinumab, 1 mg

Category:

J Code

Ilaris NDCs:

00078-0734-61

Primary Type:

Immunology:Anti-TNF

Generic/Specialty Status:

Single-Source

Package Type:

Vial

Route of Administration:

Subcutaneous

Ilaris CPT Codes:

Potential CPT administration codes for Ilaris can be found at the following link.

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Ilaris:

ILARIS is an Immunology:Anti-TNF drug manufactured by Novartis and administered via the Subcutaneous route of administration. The J Code: J0638 is aligned to the drug ILARIS.

ACCESS PRICING AND MORE BY REGISTERING

J0638 Added Date:

January 1, 2011

J0638 Effective Date:

January 1, 2011

J0638 Termination Date:

HCPCS Active

Ilaris billing and coding information can be found through Novartis at the link below:
Ilaris patient assistance information can be found through Novartis Patient Support at the URL: https://www.novartis.us/our-products/patient-assistance/patient-assistance-foundation-enrollment
ILARIS prescribing information can be found at the link below:
Information regarding ILARIS’s side effects can be found at MedlinePlus